News Stop obsessing about generic Advair, says GSK's Witty Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
News Novartis’ COPD combo show benefits in switching from establi... A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to N
News Early filing gives GSK a boost in COPD Compelling data from FULFIL study puts GSK in pole position
Views & Analysis Digital Health Round-up – new President, new ideals? A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Propeller Health set for expansion with latest funding round $21.5 million in funding will be used to expand its existing roster of digitally-guided therapy solutions.
Views & Analysis ‘Real world’ COPD trial gives GSK a dose of reality Salford Lung Study is a bold experiment, but hasn't fully paid off for GSK.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
